Preventable fractions of cancer incidence attributable to 7-years weight gain in the Norwegian Women and Cancer (NOWAC) study

被引:0
作者
Marisa da Silva
Maarit A. Laaksonen
Lauren Lissner
Elisabete Weiderpass
Charlotta Rylander
机构
[1] UiT The Arctic University of Norway,Department of Community Medicine, Faculty of Health Sciences
[2] University of New South Wales,Centre for Big Data Research in Health
[3] Institute of Medicine,School of Public Health and Community Medicine, Section for Epidemiology and Social Medicine (EPSO)
[4] Sahlgrenska Academy,undefined
[5] University of Gothenburg,undefined
[6] International Agency for Research on Cancer,undefined
[7] World Health Organization,undefined
来源
Scientific Reports | / 11卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
There is a lack of tangible measures for directed public health action to halt the increase in weight and cancer. We estimated the fraction and preventable cases of all and major body fatness-related cancers attributable to 7-years weight gain (≥ 2 kg). We assessed validated self-reported anthropometrics from 44,114 women aged 34–49 years at the enrolment in 1991–1992 and from a second questionnaire in 1998, with follow-up through December 31, 2015. Over 18 years, 3216 body fatness-related cancers and 2041 deaths were reported. Nearly 70% of women experienced weight gain and the average weight change was 4 kg. We observed a substantial proportional impact of weight gain on pancreatic cancer with a population attributable fraction (PAF) of 41.8% (95% CI 8.1–63.1) and a high absolute impact on postmenopausal breast cancer with 4403 preventable cases (95% CI 1064–7299) and a PAF of 16.8% (95% CI 4.1–27.8), and colorectal cancer with 3857 preventable cases (95% CI 1313–5990) and a PAF of 22.6% (95% CI 7.7–35.1). Avoiding weight gain over seven years in middle adulthood could have prevented a considerable proportion of the cancer burden and thousands of cancer cases in women in Norway.
引用
收藏
相关论文
共 142 条
[1]  
Bray F(2017)Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults Lancet 390 2627-2642
[2]  
Ferlay J(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J. Clin. 68 394-424
[3]  
Soerjomataram I(2016)Body fatness and cancer-viewpoint of the IARC working group N. Engl. J. Med. 375 794-798
[4]  
Siegel RL(2015)Global burden of cancer attributable to high body-mass index in 2012: A population-based study Lancet Oncol. 16 36-46
[5]  
Torre LA(2013)Young adult weight trajectories through midlife by body mass category Obesity (Silver Spring, Md). 21 1923-1934
[6]  
Jemal A(2015)Adult weight gain and adiposity-related cancers: A dose-response meta-analysis of prospective observational studies J. Natl. Cancer Inst. 119 646-656
[7]  
Lauby-Secretan B(2018)Excess body weight, weight gain and obesity-related cancer risk in women in Norway: The Norwegian Women and Cancer study Br. J. Cancer. 48 1872-1885
[8]  
Scoccianti C(2019)BMI and weight changes and risk of obesity-related cancers: A pooled European cohort study Int. J. Epidemiol. 144 967-980
[9]  
Loomis D(2019)Weight change since age 20 and incident risk of obesity-related cancer in Japan: A pooled analysis of the Miyagi Cohort Study and the Ohsaki Cohort Study Int. J. Cancer. 64 154-162
[10]  
Grosse Y(2018)Obesity and cancer: Evidence, impact, and future directions Clin. Chem. 296 193-201